Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Plain Language Summary of the iNNOVATE study: ibrutinib plus rituximab is well-tolerated and effective in people with Waldenström's macroglobulinemia.
Journal: Future oncology (London, England)
Published: February 23, 2023
Venetoclax ex vivo functional profiling predicts improved progression-free survival.
Journal: Blood cancer journal
Published: May 19, 2022
Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 04, 2021
Benefits of Autologous Stem Cell Transplantation for Elderly Myeloma Patients in the Last Quarter of Life.
Journal: Transplantation and cellular therapy
Published: June 28, 2021
Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia.
Journal: Blood cancer discovery
Published: March 05, 2021
Indatuximab ravtansine plus dexamethasone with lenalidomide or pomalidomide in relapsed or refractory multiple myeloma: a multicentre, phase 1/2a study.
Journal: The Lancet. Haematology
Published: January 11, 2021
Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia.
Journal: JCO oncology practice
Published: October 30, 2020
Natural history of multiple myeloma patients refractory to venetoclax: A single center experience.
Journal: American journal of hematology
Published: August 27, 2020
Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expression.
Journal: Blood
Published: June 26, 2020
Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 17, 2020
Outcomes of Chronic Phase Chronic Myeloid Leukemia after Treatment with Multiple Tyrosine Kinase Inhibitors.
Journal: Journal of clinical medicine
Published: March 19, 2020
Last Updated: 09/26/2026